Enabling clinical governance: A primary care audit of prescribing for heart failure in central Auckland, New Zealand

British Journal of Clinical Governance

Volumn 6, Issue 3, 2001, Pages 175-182

  Buetow, S ^a   Coster, G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Clinical audit; General practice

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; FUROSEMIDE; LOOP DIURETIC AGENT; PERHEXILINE MALEATE; POTASSIUM; THIAZIDE DIURETIC AGENT; WARFARIN;

AGED; ARTICLE; AUSTRALIA; CLINICAL MEDICINE; FEMALE; GENERAL PRACTICE; HEALTH CARE UTILIZATION; HEALTH PROMOTION; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; METHODOLOGY; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

EID: 0034794727     PISSN: 14664100     EISSN: None     Source Type: Journal    
DOI: 10.1108/EUM0000000005681     Document Type: Article

References (41)

1. A method for the detailed assessment of the appropriateness of medical technologies
2. New Zealand and United Kingdom experiences with using the RAND modified-Delphi approach to produce angina and heart failure criteria for quality assessment in general practice
3. The development of review criteria for assessing the quality of management of stable angina, adult asthma and non-insulin dependent diabetes mellitus in general practice
4. Successes and failures of current treatment of heart failure
5. Response bias in a study of general practice
6. The epidemiology of heart failure
7. The effect of cash and other financial inducements on the response rate of general practitioners in a national postal study
8. What is the quality of general practitioner records in Australia?
9. The quality of care. How can it be assessed?
10. Differences between primary care physicians and cardiologists in management of congestive heart failure: Relation to practice guidelines
11. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy: Results of the diltiazem in dilated cardiomyopathy trial
12. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
13. Coronary angioplasty compared with bypass grafting
14. The scale of heart failure: Diagnosis and management issues for primary care
15. Management of heart failure: Evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients?
16. The HOPE study - Ramipril lowered cardiovascular risk, vitamin E did not
17. Diagnosis of patients with chronic heart failure in primary care: Usefulness of history, examination, and investigations
18. Indicators of quality in health care
19. Prevalence, aetiology and management of heart failure in general practice
20. Response rates in general practice studies
21. Failure to practise evidence-based medicine: Why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?
22. Major B-blocker mortality trials in chronic heart failure: A critical review
23. New Zealand's independent practitioner associations: A working model of clinical governance in primary care?
24. Do beta-blockers prolong survival in chronic heart failure? A review of experimental evidence and clinical evidence
25. Cost-effective management of heart failure
26. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
27. History, definition and classification of heart failure
28. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
29. To what extent do clinical notes by general practitioners reflect actual medical performance? A study using simulated patients
30. Cost-effectiveness analysis in clinical practice. The case of heart failure
31. Clinical governance and the drive for quality improvement in the new NHS in England
32. Epidemiology of heart failure and ventricular dysfunction
33. The treatment of heart failure
34. Surveying general practitioners: Does a low response rate matter?
35. Relationship between practice organization and cardiovascular risk factor recording in general practice